XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF EQUITY
¥ in Thousands, $ in Thousands
Common stock
shares
Additional Paid-in Capital
CNY (¥)
Additional Paid-in Capital
USD ($)
Accumulated Deficit Unrestricted
CNY (¥)
Accumulated Deficit Unrestricted
USD ($)
Accumulated Other Comprehensive Loss
CNY (¥)
Accumulated Other Comprehensive Loss
USD ($)
Treasury Stock
CNY (¥)
Treasury Stock
USD ($)
Non-controlling Interests
CNY (¥)
Non-controlling Interests
USD ($)
CNY (¥)
USD ($)
Beginning balance at Sep. 30, 2020   ¥ 514,675   ¥ (559,104)   ¥ (22,405)   ¥ (10,356)   ¥ (8,272)   ¥ (85,462)  
Beginning balance (in shares) at Sep. 30, 2020 | shares [1] 5,431,724                        
Net loss for the year       (91,529)           (35,552)   (127,081)  
Exercise of share option   745                   745  
Exercise of share option (in shares) | shares [1] 21,930                        
Share-based compensation expense   6,729           4,223       10,952  
Business disposal                   (1,102)   (1,102)  
Issuance of common shares   17,166                   17,166  
Issuance of common shares (in shares) | shares [1] 319,440                        
Translation adjustments           (816)           (816)  
Ending balance at Sep. 30, 2021   539,315   (650,633)   (23,221)   (6,133)   (44,926)   (185,598)  
Ending balance (in shares) at Sep. 30, 2021 | shares [1] 5,773,094                        
Net loss for the year       (6,265)           8,590   2,325  
Exercise of share option   566                   566  
Exercise of share option (in shares) | shares [1] 16,510                        
Share-based compensation expense   1,038                   1,038  
Business disposal                   (2,434)   (2,434)  
Issuance of common shares   11,014                   11,014  
Issuance of common shares (in shares) | shares [1] 201,000                        
Translation adjustments       447               447  
Ending balance at Sep. 30, 2022   551,933   (656,898)   (22,774)   (6,133)   (38,770)   (172,642)  
Ending balance (in shares) at Sep. 30, 2022 | shares [1] 5,990,604                        
Net loss for the year       55,332           7,337   62,669 $ 8,728
Capital contribution from NCI                   10,475   10,480 1,460
Exercise of share option   599                   599  
Exercise of share option (in shares) | shares [1] 10,503                        
Share-based compensation expense   1,163                   1,163  
Business disposal                   (2,704)   (2,704)  
Dividend                   (200)   (200)  
Issuance of common shares   19,594                   19,594  
Issuance of common shares (in shares) | shares [1] 320,000                        
Translation adjustments           (214)           (214) (30)
Ending balance at Sep. 30, 2023   ¥ 573,289 $ 79,847 ¥ (601,566) $ (83,786) ¥ (22,988) $ (3,202) ¥ (6,133) $ (854) ¥ (23,862) $ (3,323) ¥ (81,260) $ (11,318)
Ending balance (in shares) at Sep. 30, 2023 | shares [1] 6,321,107                        
[1] Retrospectively restated for effect of reverse stock split